Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 15;8(2):253-265.
doi: 10.3945/an.116.013730. Print 2017 Mar.

Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease

Christine C Hsu  1 , Erik Ness, Kris V Kowdley  2
Affiliations
Review

Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease

Christine C Hsu et al. Adv Nutr. .

Abstract

Nonalcoholic fatty liver disease (NAFLD) can range in spectrum from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), which is characterized by lipotoxicity, hepatocellular ballooning, and inflammation and can progress to cirrhosis. Weight loss is the cornerstone treatment for NAFLD and NASH. Various randomized controlled trials have shown that weight loss of ≥5-10% leads to significant improvements in hepatic steatosis. Diets high in sodium and fructose have been implicated in the pathogenesis of NAFLD. Although some clinical studies suggest that an isocaloric high-fructose diet does not worsen NAFLD, these clinical studies are often short in duration. More recently, the Dietary Approaches to Stop Hypertension diet, a sodium-restricted diet, has been associated with less prevalence of NAFLD and has been shown to improve NAFLD. In addition, the Mediterranean diet has been promising in improving hepatic steatosis, and a larger randomized controlled trial is currently enrolling subjects. For those who are unable to pursue weight loss through dietary approaches, bariatric surgery has been shown to improve hepatic steatosis and steatohepatitis. This method has been variable in improving hepatic fibrosis. In conclusion, weight loss is crucial to the improvement of NAFLD and NASH, and patients should attempt various diets in an attempt to achieve weight loss.

Keywords: DASH diet; bariatric surgery; liver disease; metabolic syndrome; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; obesity; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: KV Kowdley is on the advisory board for Enanta, Gilead, Intercept, and Verlyx. He is also a consultant for Gilead, Enanta, and Intercept, and is on the speaker bureau for Intercept. E Ness is on the advisory board for Gilead and on the speaker bureau for Gilead and Intercept. CC Hsu, no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
NAFLD patients (n = 154) randomly assigned to a dietitian-led lifestyle modification compared with standard of care for 12 mo. The figure represents the percentage of patients who had NAFLD resolution according to the percentage of weight loss when compared with their baseline. P-trend < 0.001. NAFLD, nonalcoholic fatty liver disease. Adapted from reference with permission.
FIGURE 2
FIGURE 2
NASH patients (n = 293) who underwent 52 wk of lifestyle changes. This figure represents hepatic fibrosis stabilization, regression, or worsening according to the percentage of weight loss from baseline to 52 wk. P = 0.04. NASH, nonalcoholic steatohepatitis. Adapted from reference 48 with permission.
See this image and copyright information in PMC

References

    1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association; American Association for the Study of Liver Diseases; et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592–609. - PubMed
    1. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015;313:2263–73. - PubMed
    1. Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, Linder K. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 2005;41:64–71. - PubMed
    1. Whalley S, Puvanachandra P, Desai A, Kennedy H. Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs. Clin Med (Lond) 2007;7:119–24. - PMC - PubMed
    1. Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:511–31. - PubMed